What happened, in summary

This story was shared by a pharmacist caring for her uncle after he was diagnosed in July 2020 with inoperable small cell lung cancer. Doctors estimated a life expectancy of 7 months with chemotherapy. Alongside chemotherapy, his caregiver introduced artemisinin, desmodium, and nutritional supplements. She described him as tolerating chemotherapy without major side effects and staying relatively well. When the lung tumor shrank by 24%, doctors moved forward with radiation. During 45 days of radiation, the metabolic approach was paused, and he developed 2 brain metastases that affected use of his arm and hand. His caregiver then asked for artemisinin to be restarted on weekends without radiation. After 2 doses, his arm began moving for a few minutes each day, and function gradually returned, though his fingers still needed rehabilitation. When radiation ended, the full metabolic regimen was resumed. A control scan later showed that the brain metastases had disappeared. One year after diagnosis, he was still continuing the regimen and hoping for more good news. His experience highlights how quickly SCLC can change, and how important close imaging, symptom monitoring, and coordinated oncology care are when brain metastases appear.